Helix BioPharmaHBPCF 28 ROA % is -13.46% as of Apr. 2026. GuruFocus rates HBPCF with a GF Score™ of 28/100. Among 1,423 Biotechnology companies, Helix BioPharma ranks better than 59.1% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Helix BioPharma's annualizedNet Income for the quarter that ended in Apr. 2026 was $-1.95 Mil.
Helix BioPharma's average Total Assets over the quarter that ended in Apr. 2026 was $14.50 Mil. Therefore, Helix BioPharma's annualized ROA % for the quarter that ended in Apr. 2026 was -13.46%.
The historical rank and industry rank for Helix BioPharma's ROA % or its related term are showing as below:
HBPCF'
s ROA % Range Over the Past 10 Years
Min: -735.82 Med: -283.3 Max: -21.09
Current: -21.09
During the past 13 years, Helix BioPharma's highest ROA % was -21.09%. The lowest was -735.82%. And the median was -283.30%.
HBPCF's ROA % is ranked better than 59.1% of 1423
companies
in the Biotechnology industry
Industry Median: -32.9
vs HBPCF: -21.09
Helix BioPharma (OTCPK:HBPCF) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Apr. 2026) net income data. The Revenue data used here is four times the quarterly (Apr. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Helix BioPharma ROA % Related Terms
Helix BioPharma ROA % Historical Data
* Premium members only.
The historical data trend for Helix BioPharma's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Helix BioPharma's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Helix BioPharma ROA % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Helix BioPharma's ROA % distribution charts can be found below:
* The bar in red indicates where Helix BioPharma's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Apr. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Helix BioPharma (HBPCF) has a ROA % of -13.46% as of Apr. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Helix BioPharma and its competitors. According to the industry distribution chart, Helix BioPharma ranks #582 out of 1423 companies in the Biotechnology industry, placing it in the top 40.9%.
Is Helix BioPharma's ROA % too high?
Helix BioPharma's current ROA % is -13.46%. Based on the distribution chart, Helix BioPharma ranks #582 out of 1423 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Helix BioPharma has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Helix BioPharma's ROA % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Helix BioPharma ranks #582 out of 1423 companies for ROA %. This puts Helix BioPharma in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Biotechnology company?
A good ROA % depends on the Biotechnology industry context. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Helix BioPharma and its competitors. Helix BioPharma's current ROA % is -13.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Helix BioPharma stock overvalued right now?
Helix BioPharma (HBPCF) has a current ROA % of -13.46%. The current ROA % is -13.46%. Helix BioPharma's overall GF Score™ is 28/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Helix BioPharma (HBPCF), the current ROA % is -13.46% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Helix BioPharma Corp is a clinical-stage biopharmaceutical company developing therapies in immune-oncology focused on cancer prevention and treatment. The Company is developing a proprietary platform of bio-conjugates targeting hard-to-treat solid tumors over-expressing CEACAM6, including Tumor Defense Breaker, L-DOS47, and three CEACAM6-specific antibody-drug conjugates. Its pre-IND candidates include LEUMUNA, an oral immune checkpoint modulator for hematological malignancies, and GEMCEDA, an oral prodrug of gemcitabine for solid tumors.
28GF Score
Get the complete analysis for HBPCF
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HBPCF has been successfully added to your 
